Total Payments
$121,359
2024 Payments
$7,127
Companies
29
Transactions
506
Medicare Patients
1,481
Medicare Billing
$192,767
Payment Breakdown by Category
Other$86,513 (71.3%)
Consulting$19,063 (15.7%)
Food & Beverage$9,047 (7.5%)
Travel$6,731 (5.5%)
Education$5.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $84,013 | 46 | 69.2% |
| Consulting Fee | $19,063 | 9 | 15.7% |
| Food and Beverage | $9,047 | 410 | 7.5% |
| Travel and Lodging | $6,731 | 38 | 5.5% |
| Honoraria | $2,500 | 2 | 2.1% |
| Education | $5.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $57,507 | 128 | $0 (2023) |
| Optinose US, Inc. | $53,019 | 125 | $0 (2024) |
| Greer Laboratories, Inc. | $6,845 | 22 | $0 (2022) |
| GlaxoSmithKline, LLC. | $902.65 | 83 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $710.22 | 31 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $462.36 | 27 | $0 (2023) |
| ALK-Abello, Inc | $366.04 | 10 | $0 (2020) |
| Genentech USA, Inc. | $310.85 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $185.42 | 3 | $0 (2024) |
| kaleo, Inc. | $131.90 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,127 | 23 | Optinose US, Inc. ($6,838) |
| 2023 | $10,964 | 41 | Teva Pharmaceuticals USA, Inc. ($8,819) |
| 2022 | $16,909 | 77 | Teva Pharmaceuticals USA, Inc. ($9,087) |
| 2021 | $36,729 | 75 | Teva Pharmaceuticals USA, Inc. ($22,562) |
| 2020 | $4,284 | 52 | OptiNose US, Inc. ($3,661) |
| 2019 | $21,269 | 75 | OptiNose US, Inc. ($11,552) |
| 2018 | $14,121 | 98 | Optinose US, Inc. ($8,032) |
| 2017 | $9,956 | 65 | Greer Laboratories, Inc. ($6,745) |
All Payment Transactions
506 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $920.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/14/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/19/2024 | Jubilant HollisterStier LLC | — | Food and Beverage | In-kind items and services | $14.44 | General |
| 09/17/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $129.54 | General |
| 09/09/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $920.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/23/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $920.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/07/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $920.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/01/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/16/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,495.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/16/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $21.87 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/16/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.00 | General |
| 04/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/11/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Immunology | ||||||
| 03/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Respiratory | ||||||
| 02/24/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $48.09 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/21/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/05/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/01/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/01/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 351 | 4,958 | $122,195 | $44,314 |
| 2022 | 6 | 332 | 3,981 | $92,451 | $41,021 |
| 2021 | 8 | 406 | 5,066 | $112,588 | $55,690 |
| 2020 | 8 | 392 | 4,497 | $129,209 | $51,742 |
Total Patients
1,481
Total Services
18,502
Medicare Billing
$192,767
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 210 | $36,750 | $18,688 | 50.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 76 | 4,287 | $49,301 | $12,213 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $26,730 | $11,076 | 41.4% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 16 | 201 | $3,618 | $1,202 | 33.2% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 16 | 161 | $5,796 | $1,136 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 173 | $28,497 | $16,241 | 57.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 94 | 94 | $23,970 | $11,104 | 46.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 66 | 3,482 | $27,856 | $10,600 | 38.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 21 | 203 | $7,308 | $1,509 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $1,810 | $997.70 | 55.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 15 | 15 | $3,010 | $570.68 | 19.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 120 | 162 | $25,434 | $15,555 | 61.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 124 | 124 | $30,008 | $15,544 | 51.8% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 78 | 4,098 | $32,784 | $12,676 | 38.7% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 13 | 450 | $9,000 | $5,441 | 60.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 21 | $4,410 | $2,854 | 64.7% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 18 | 175 | $6,300 | $1,330 | 21.1% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Office | 2021 | 18 | 19 | $2,850 | $1,196 | 42.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 17 | $1,802 | $1,093 | 60.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 122 | 163 | $24,770 | $13,242 | 53.5% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 64 | 3,364 | $36,554 | $10,878 | 29.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 87 | 87 | $20,445 | $9,397 | 46.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 59 | 63 | $12,848 | $6,605 | 51.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 15 | 615 | $12,300 | $6,355 | 51.7% |
| 95806 | Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort | Office | 2020 | 14 | 30 | $12,300 | $2,714 | 22.1% |
About Dr. Samuel Friedlander, M.D
Dr. Samuel Friedlander, M.D is a Internal Medicine healthcare provider based in Solon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689630345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Friedlander, M.D has received a total of $121,359 in payments from pharmaceutical and medical device companies, with $7,127 received in 2024. These payments were reported across 506 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($84,013).
As a Medicare-enrolled provider, Friedlander has provided services to 1,481 Medicare beneficiaries, totaling 18,502 services with total Medicare billing of $192,767. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Allergy & Immunology
- Location Solon, OH
- Active Since 04/21/2006
- Last Updated 01/08/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689630345
Products in Payments
- Xhance (Drug) $53,019
- CINQAIR (Biological) $26,360
- ProAir Digihaler (Drug) $9,022
- Oralair (Drug) $6,745
- ArmonAir Digihaler (Drug) $4,972
- QVAR (Drug) $4,854
- AIRDUO (Drug) $2,032
- CINQAIR (Drug) $637.04
- PROAIR RESPICLICK (Drug) $500.00
- NUCALA (Biological) $473.32
- Odactra (Drug) $323.08
- Xolair (Biological) $310.85
- Xyrem (Drug) $304.03
- TEZSPIRE (Biological) $273.02
- TRELEGY ELLIPTA (Drug) $218.51
- BREO (Drug) $180.70
- FASENRA (Drug) $169.81
- AUVI-Q (Drug) $119.34
- RUCONEST (Biological) $113.90
- Wakix (Drug) $109.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Solon
Dr. Jeffrey Chaitoff, Md, MD
Internal Medicine — Payments: $4,005
Internal Medicine $4,005
Jayanthi Alagarsamy, Md, MD
Internal Medicine — Payments: $3,318
Internal Medicine $3,318
Riaz Ahmad, Md, MD
Internal Medicine — Payments: $2,408
Internal Medicine $2,408
Dr. Lauren Walter, D.o, D.O
Internal Medicine — Payments: $1,278
Internal Medicine $1,278
Amelita Quedding-Pizarro, Md, MD
Internal Medicine — Payments: $665.85
Internal Medicine $665.85
Dr. Erin Rocchio, D.o, D.O
Internal Medicine — Payments: $628.28
Internal Medicine $628.28